RESUMO

INTRODUCTION/AIMS: Carriers of DMD pathogenic variants may become symptomatic and develop muscle-related manifestations. Despite that, few studies have attempted to characterize changes in the muscles of these carriers using imaging tools, particularly muscle ultrasound (MUS). The aim of this study was to compare lower limb MUS findings in carriers of DMD pathogenic variants (cDMD) vs healthy controls. METHODS: Twenty-eight women (15 cDMD and 13 controls) underwent clinical evaluation and MUS. We collected information about muscle-related symptoms and assessed muscle strength. MUS was performed by a single physician (blind to the genetic status of subjects). The following muscles were assessed: rectus femoris, sartorius, tibialis anterior, and medial gastrocnemius. For each site, we computed data on muscle thickness, cross-sectional area, sound attenuation index, and elastography. Between-group comparisons were assessed using nonparametric tests and p-values <.05 were deemed significant. RESULTS: None of the subjects had objective muscle weakness, but exercise intolerance/fatigue was reported by four cDMDs and only one control. Regarding MUS, sound attenuation indices were significantly higher among carriers for all muscles tested. Longitudinal and axial deep echo intensities for the rectus femoris and tibialis anterior were also higher in the cDMD group compared with controls. No significant between-group differences were noted for elastography values, muscle area, or mean echo intensities. DISCUSSION: cDMD have skeletal muscle abnormalities that can be detected using quantitative MUS. Further studies are needed to determine whether such abnormalities are related to muscle symptoms in these patients.

Assuntos

RESUMO

INTRODUCTION AND OBJECTIVES: The use of neuromuscular blockers during surgery represented a landmark for anesthesiology. However, their use can prompt residual Neuromuscular Blockade (RNMB) and objective monitoring of neuromuscular function is crucial to warrant the recovery of muscle strength. The present study aimed to estimate the incidence of RNMB and late Neuromuscular Blockade (LNMB) at the Post-Anesthetic Recovery Unit (PACU). METHOD: The study included 85 patients, 43 of which received cisatracurium and 42 of which, rocuronium. The depth of the Neuromuscular Blockade (NMB) was assessed by Train Of Four (TOF). NMB reversal was performed with the administration of neostigmine and atropine.RNMB was defined when a patient presented TOF below 90% at the PACU. RESULTS: RNMB at the PACU was diagnosed in 39.5% and 40.5% of the patients receiving cisatracurium and rocuronium, respectively (p = 1.0). LNMB at the PACU was found in 32.6% and 16.7% of the patients receiving cisatracurium and rocuronium, respectively (p = 0.131). CONCLUSIONS: The incidence ofRNMB remains significant despite the use of intermediate-acting neuromuscular blockers and reversal agents. There was no statistically significant difference in the incidence of RNMB or LNMB in patients receiving cisatracurium or rocuronium. The use of objective NMB monitoring is effective for the diagnosis of RNMB, as well as for treatment management.

Assuntos

RESUMO

o estudo teve como objetivo verificar as adaptações geradas pelo treinamento de força (TF) nos parâmetros neuromusculares e na composição corporal de adolescentes. A amostra foi composta por 10 adolescentes do sexo masculino (16,4 ± 1,0 anos), o protocolo de treinamento de força teve duração de 10 semanas com 3 sessões semanais, divididos em treinos A e B. Para comparação do desempenho, foram avaliadas variáveis antropométricas e composição corporal (estatura, peso, índice de massa corporal e percentual de gordura), bem como, neuromusculares, por meio da resistência muscular de membros superiores (teste de flexão de braços), força explosiva de membros inferiores (teste de salto horizontal), flexibilidade (teste de sentar e alcançar), e força muscular (supino, puxada e leg press 45º). Para comparar os resultados pré e pós intervenção foram utilizadas as diferenças de médias estandardizadas e seus respectivos intervalos de confiança (IC= 90%) e as probabilidades (maior/similar/menor). Foram encontrados aumentos substanciais entre os períodos pré e pós intervenção, para a resistência muscular localizada de membros superiores (92/7/1, Likely), um impacto benéfico de força no supino (86/11/2, Likely), puxada (82/15/3, Likely) e leg press 45° (84/14/2, Likely), e redução em média de 3% na gordura corporal. Os resultados contribuem para uma reflexão crítica em relação ao incentivo a prática de TF em adolescentes, pois com supervisão adequada, planejamento, individualização das cargas de treino e educação técnica correta de cada exercício, os riscos foram suprimidos e os benefícios amplificados.(AU)

Our aim was to investigate the adaptations caused by strength training (ST) in neuromuscular parameters and body composition of adolescents. The sample consisted of 10 male adolescents (16.4 ± 1.0 years) and the strength training protocol lasted 10 weeks with 3 weekly sessions, divided into training sessions A and B. Anthropometric variables and body composition (height, weight, body mass index and percentage of fat) as well as neuromuscular performance (upper limb endurance strength, horizontal jump height, flexibility and muscle strength in bench-press, lat pull-down and 45º leg press exercises). Pre- and post-intervention results were compared using standardized mean differences and their respective confidence intervals (CI = 90%) and likelihood (greater / similar / lower). Substantial increases were found between the pre- and post-intervention periods for upper-limb muscle endurance (92/7/1, Likely) and bench press (86/11/2, Likely), lat pull-down (82 / 15/3, Likely) and leg press (84/14/2, Likely) strength, while a beneficial reduction of 3% in body fat was observed. The results contribute to a critical reflection regarding the incentive to practice ST in adolescents. With proper supervision, planning, individualization of training loads and correct technical education of each exercise, the potential risks were suppressed and the benefits amplified.(AU)

Assuntos

RESUMO

Abstract Background: Sugammadex has made it possible to reverse any type of rocuronium-induced block quickly and safely. The most frequent neuromuscular blockade is the moderate one where doses smaller than those recommended by the industry could get a full reversal. Objective: We aimed to evaluate the effectiveness of half the industry recommended dose of sugammadex to reverse a moderate neuromuscular block. Methods: Unicenter phase IV clinical trial that included 34 patients undergoing laparoscopic cholecystectomy. Intravenous general anesthesia was induced, with acceleromyographic monitoring of the neuromuscular block. After the intervention, the block was reversed with all or half the dose of sugammadex recommended for moderate blocks, using a blinded syringe. Results: Patient characteristics of the 2 groups were similar. Mean time to recovery was 3.6± 1.7minutes for the study group and 3.1 ± 1.7minutes for the control group (P=0.42). Reversal of the block was complete with a single dose of sugammadex in all patients. There was an important linear correlation between depth of block and time to recovery. Conclusion: Intraoperative monitoring is essential to allow us to individualize the dose of the neuromuscular blocking agent. To reverse a moderate block under neuromuscular monitoring, a dose of 1 mg/kg is sufficient in most cases and is equally safe and effective.

Resumen Introducción: El sugammadex permite revertir cualquier tipo de bloqueo inducido por rocuronio de forma rápida y segura. El bloqueo neuromuscular más frecuente es el moderado, en el cual dosis inferiores a las recomendadas por la industria podrían revertirlo completamente. Objetivo: Evaluar la efectividad de la mitad de la dosis de sugammadex recomendada por la industria para revertir un bloqueo neuromuscular moderado. Métodos: Ensayo clínico de fase IV en un unico centro que incluyó a 34 pacientes intervenidos de colecistectomía laparoscópica. Se realizó anestesia general intravenosa con monitoreo aceleromiográfico del bloqueo neuromuscular. Tras la intervención, el bloqueo se revirtió con la totalidad o con la mitad de la dosis de sugammadex recomendada para bloqueos moderados, utilizando una jeringa ciega. Resultados: Las características de los pacientes de los dos grupos fueron similares. La media de tiempo de recuperación fue de 3,6 ± 1,7 minutos para el grupo de estudio y de 3,1 ± 1,7 minutos para el grupo de control (p = 0,42). La reversión del bloqueo se completó con una dosis única de sugammadex en todos los pacientes. Hubo una correlación lineal importante entre la profundidad del bloqueo y el tiempo de recuperación. Conclusión: El monitoreo transquirúrgico es esencial para individualizar la dosis del agente de bloqueo neuromuscular. Para revertir un bloqueo moderado bajo monitoreo neuromuscular, una dosis de 1mg/kg es suficiente e igualmente segura y efectiva.

Assuntos

RESUMO

Objetivo: Determinar la incidencia y severidad de la parálisis residual en pacientes sin monitorización neuromuscular intraoperatoria. Materiales y métodos: Se realizó un estudio prospectivo y observacional en 236 pacientes adultos ASA I-III intervenidos bajo anestesia general sin monitorización neuromuscular intraoperatoria. A su llegada a la Unidad de Cuidados Post-Anestesia (UCPA) se realizó la monitorización neuromuscular mediante aceleromiografía del músculo aductor del pulgar. La incidencia de parálisis residual con TOF ratio (TOFr) < 0,9 y TOFr < 0,7 fueron valorados. Resultados: La incidencia de parálisis residual en la UCPA con TOFr < 0,9 fue de 81,36% (IC 95%: 76,39-86,33) y con TOFr < 0,7 fue de 33,9% (IC 95%: 27,86-39,94). La neostigmina fue utilizada para revertir el bloqueo neuromuscular solamente en el 48,3% de los casos. La incidencia de parálisis residual con TOFr < 0,7 fue significativamente mayor entre los que no recibieron antagonistas del bloqueo neuromuscular y los que sí lo recibieron (42,62% vs. 24,56%, p=0.003). Conclusiones: La incidencia y severidad de la parálisis residual posoperatoria en pacientes sin monitorización neuromuscular fue elevada en nuestra institución, probablemente favorecida por una dosificación no guiada de los relajantes musculares, la escasa utilidad de los criterios subjetivos para valorar la recuperación de la función neuromuscular y la falta de reversión rutinaria del bloqueo neuromuscular.

Objective: To determine both the incidence and severity of residual paralysis in patients not undergoing intraoperative neuromuscular monitoring. Material and Methods: A prospective observational study was performed in 236 ASA I-III adult subjects who underwent surgery under general anesthesia without intraoperative neuromuscular monitoring. When patients were brought to the Post-Anesthesia Care Unit (PACU), neuromuscular monitoring was performed using acceleromiography of the adductor muscle of the thumb. The incidence of residual paralysis with TOF ratio (TOFr) values <0.9 and <0.7 was assessed. Results: The incidence of residual paralysis in the PACU with TOFr <0.9 was 81.36% (95% CI: 76.39%-86.33%) and with TOFr <0.7 was 33.9% (95% CI: 27.86%-39.94%). Neostigmine was used to revert neuromuscular blockade only in 48.3% of all cases. The incidence of residual paralysis with TOFr<0.7 was significantly higher in those subjects who did not receive neuromuscular blockade antagonists compared with those who did (42.62% vs. 24.56%, p= 0.03). Conclusions: Both the incidence and severity of residual postoperative paralysis in patients without neuromuscular monitoring was notoriously high in our institution, likely favored by a non-guided dosing of muscle relaxant agents, as well as due to low usefulness of subjective criteria for assessing recovery of neuromuscular function and the lack of routine reversion of neuromuscular blockade.

RESUMO

BACKGROUND: After reversal of a rocuronium-induced neuromuscular blockade with sugammadex, the recovery of train-of-four ratio to 0.9 is faster than recovery of first twitch of the train-of-four to 90% in adults. These findings after reversal of neuromuscular blockade with sugammadex have not yet been investigated in pediatric patients. AIMS: The aim of this retrospective analysis was to investigate the relationship of the recovery of first twitch of the train-of-four height and train-of-four ratio after reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric patients. METHODS: Patients ASA I-III, aged 2-11 years, and who underwent abdominal and/or perineal surgery were included in the analysis. After extracting the necessary data from the hospital database, the patients were divided into 2 groups based on the dose of sugammadex received: group A: 2 mg.kg-1 for reversal of moderate neuromuscular blockade and group B: 4 mg.kg-1 for reversal of deep neuromuscular blockade. The relationship of the recovery of first twitch of the train-of-four height and train-of-four ratio in these 2 groups were analyzed. RESULTS: Data from 43 pediatric patients aged 2-11 years could be analyzed. The first twitch of the train-of-four height at the recovery of train-of-four ratio to 0.9 in group B was statistically significantly lower compared with group A. This height 3 and 5 minutes after the train-of-four ratio reached 0.9 showed no statistically significant differences between groups. CONCLUSION: The results were in line with the results found in adults and showed that the train-of-four ratio recovered to 0.9 was faster than first twitch of the train-of-four height recovered to the same level.

Assuntos

RESUMO

Abstract Objective Evaluate the incidence of postoperative residual curarization (PORC) in the post-anesthesia care unit (PACU) after the use of protocol and absence of intraoperative acceleromyography (AMG). Methods Randomized clinical trial with 122 patients allocated into two groups (protocol and control). Protocol group received initial and additional doses of rocuronium (0.6 mg·kg-1 and 10 mg, respectively); the use of rocuronium was avoided in the final 45 min; blockade reversal with neostigmine (50 µg·kg-1); time ≥15 min between reversion and extubation. Control: initial and additional doses of rocuronium, blockade reversal, neostigmine dose, and extubation time, all at the discretion of the anesthesiologist. AMG was used in the PACU and PORC considered at T4/T1 ratio <1.0. Results The incidence of PORC was lower in protocol group than in control group (25% vs. 45.2%, p = 0.02). In control group, total dose of rocuronium was higher in patients with PORC than without PORC (0.43 vs. 0.35 mg·kg-1·h-1, p = 0.03) and the time interval between the last administration of rocuronium and neostigmine was lower (75.0 vs. 101.0 min, p < 0.01). In protocol group, there was no difference regarding the analyzed parameters (with PORC vs. without PORC). Considering the entire study population and the presence or absence of PORC, total dose of rocuronium was higher in patients with PORC (0.42 vs. 0.31 mg·kg-1·h-1, p = 0.01), while the time interval between the last administration of rocuronium and neostigmine was lower (72.5 vs. 99.0 min, p ≤ 0.01). Conclusion The proposed systematization reduced PORC incidence in PACU in the absence of intraoperative AMG.

Resumo Objetivo Avaliou-se a incidência de curarização residual pós-operatória (CRPO) na sala de recuperação pós-anestésica (SRPA) após emprego de protocolo e ausência de aceleromiografia (AMG) intraoperatória. Métodos Ensaio clínico, aleatório, com 122 pacientes, distribuídas em dois grupos: protocolo e controle. Protocolo: dose inicial e adicionais de rocurônio foram de 0,6 mg.kg-1 e 10 mg, respectivamente; evitou-se o uso de rocurônio nos 45 minutos finais; reversão do bloqueio com neostigmina (50 µg.kg-1); tempo ≥ 15 minutos entre reversão e extubação. Controle: doses inicial e adicional de rocurônio, reversão do bloqueio, dose de neostigmina e momento da extubação decididos pelo anestesiologista. Foi usada AMG na SRPA e considerado CRPO razão T4/T1 < 1,0. Resultados A incidência de CRPO foi menor no grupo protocolo em relação ao controle (25% vs. 45,2%; p = 0,02). No grupo controle, a dose total de rocurônio foi maior em pacientes com CRPO em relação àqueles sem CRPO (0,43 vs. 0,35 mg.kg-1.h-1; p = 0,03) e o intervalo entre a última administração de rocurônio e a neostigmina foi menor (75,0 vs. 101,0 min; p < 0,01). No grupo protocolo não houve diferença dos parâmetros analisados (com CRPO vs. sem CRPO). Considerando toda a população de estudo e a presença ou não de CRPO, a dose total de rocurônio foi maior em pacientes com CRPO (0,42 vs. 0,31 mg.kg-1.h-1; p = 0,01), enquanto o intervalo entre a última administração de rocurônio e a neostigmina foi menor (72,5 vs. 99,0 min; p ≤ 0,01). Conclusão A sistematização proposta reduziu a incidência de CRPO na SRPA na ausência de AMG intraoperatória.

Assuntos

RESUMO

OBJECTIVE: Evaluate the incidence of postoperative residual curarization (PORC) in the post-anesthesia care unit (PACU) after the use of protocol and absence of intraoperative acceleromyography (AMG). METHODS: Randomized clinical trial with 122 patients allocated into two groups (protocol and control). Protocol group received initial and additional doses of rocuronium (0.6mg.kg-1 and 10mg, respectively); the use of rocuronium was avoided in the final 45minutes; blockade reversal with neostigmine (50µg.kg-1); time ≥ 15minutes between reversion and extubation. CONTROL: initial and additional doses of rocuronium, blockade reversal, neostigmine dose, and extubation time, all at the discretion of the anesthesiologist. AMG was used in the PACU and PORC considered at T4/T1 ratio<1.0. RESULTS: The incidence of PORC was lower in protocol group than in control group (25% vs. 45.2%, p=0.02). In control group, total dose of rocuronium was higher in patients with PORC than without PORC (0.43 vs. 0.35mg.kg-1.h-1, p=0.03) and the time interval between the last administration of rocuronium and neostigmine was lower (75.0 vs. 101.0min, p<0.01). In protocol group, there was no difference regarding the analyzed parameters (with PORC vs. without PORC). Considering the entire study population and the presence or absence of PORC, total dose of rocuronium was higher in patients with PORC (0.42 vs. 0.31mg.kg-1.h-1, p=0.01), while the time interval between the last administration of rocuronium and neostigmine was lower (72.5 vs. 99.0min, p ≤ 0.01). CONCLUSION: The proposed systematization reduced PORC incidence in PACU in the absence of intraoperative AMG.

Assuntos

RESUMO

ABSTRACTThe objective of this study was to evaluate how Brazilian anesthesiologists are using neuromuscular blockers, focusing on how they establish the diagnosis of postoperative residual curarization and the incidence of complications associated with the use of neuromuscular blockers. A questionnaire was sent to anesthesiologists inviting them to participate in the study. The online data collection remained open from March 2012 to June 2013. During the study period, 1296 responses were collected. Rocuronium, atracurium, and cisatracurium were the main neuromuscular blockers used in cases of elective surgery. Succinylcholine and rocuronium were the main neuromuscular blockers used in cases of emergency surgery. Less than 15% of anesthesiologists reported the frequent use of neuromuscular function monitors. Only 18% of those involved in the study reported that all workplaces have such a monitor. Most respondents reported using only the clinical criteria to assess whether the patient is recovered from the muscle relaxant. Most respondents also reported always using some form of neuromuscular blockade reversal. The major complications attributed to neuromuscular blockers were residual curarization and prolonged blockade. Eighteen anesthesiologists reported death attributed to neuromuscular blockers. Residual or prolonged blockade is possibly recorded as a result of the high rate of using clinical criteria to diagnose whether the patient has recovered or not from motor block and, as a corollary, the poor use of neuromuscular transmission monitors in daily practice.

RESUMOO objetivo desta pesquisa foi avaliar como os anestesiologistas brasileiros estão usando os bloqueadores neuromusculares (BNM), com foco na forma de estabelecer o diagnóstico da curarização residual pós-operatória e a incidência de complicações atribuídas ao uso de BNM. Um questionário foi enviado a anestesiologistas convidando-os a participar da pesquisa (tabela 1). A coleta online de dados permaneceu aberta de março de 2012 a junho de 2013. Durante o período de estudo foram coletadas 1.296 respostas. Rocurônio, atracúrio e cisatracúrio foram os principais bloqueadores neuromusculares usados em casos de cirurgia eletiva. Succinilcolina e rocurônio foram os principais BNM usados em casos de cirurgia de emergência. Menos de 15% dos anestesiologistas referiram que usam frequentemente monitores da função neuromuscular. Apenas 18% dos envolvidos no estudo referiram que todos os locais de trabalho têm tal monitor. A maioria dos entrevistados afirmou que usa somente o critério clínico para avaliar se o paciente está recuperado do relaxante. A maioria dos entrevistados também relatou que sempre usa algum tipo de reversão de bloqueio neuromuscular. As principais complicações atribuídas aos BNM foram curarização residual e bloqueio prolongado. Houve relato por 18 anestesiologistas de óbito atribuído a BNM. O bloqueio residual ou prolongado se registra, possivelmente, como consequência do alto índice do uso de critérios clínicos para diagnosticar se o paciente está recuperado ou não do bloqueio motor e, como um corolário, o baixo uso de monitores da transmissão neuromuscular na prática diária.

Assuntos

RESUMO

The objective of this study was to evaluate how Brazilian anesthesiologists are using neuromuscular blockers, focusing on how they establish the diagnosis of postoperative residual curarization and the incidence of complications associated with the use of neuromuscular blockers. A questionnaire was sent to anesthesiologists inviting them to participate in the study. The online data collection remained open from March 2012 to June 2013. During the study period, 1296 responses were collected. Rocuronium, atracurium, and cisatracurium were the main neuromuscular blockers used in cases of elective surgery. Succinylcholine and rocuronium were the main neuromuscular blockers used in cases of emergency surgery. Less than 15% of anesthesiologists reported the frequent use of neuromuscular function monitors. Only 18% of those involved in the study reported that all workplaces have such a monitor. Most respondents reported using only the clinical criteria to assess whether the patient is recovered from the muscle relaxant. Most respondents also reported always using some form of neuromuscular blockade reversal. The major complications attributed to neuromuscular blockers were residual curarization and prolonged blockade. Eighteen anesthesiologists reported death attributed to neuromuscular blockers. Residual or prolonged blockade is possibly recorded as a result of the high rate of using clinical criteria to diagnose whether the patient has recovered or not from motor block and, as a corollary, the poor use of neuromuscular transmission monitors in daily practice.

Assuntos

RESUMO

Abstract The aim of this study was to assess the neuromuscular profile of handball (TH) players during a short-term condensed competition. Nine TH athletes (age: 23 ± 3 years; height: 176.2 ± 10.5 cm; mass: 75.3 ± 8.6 kg) played 5 handball matches in 5 consecutive days and had exercise-induced muscle damage (EIMD) markers such as soreness (SOR), thigh circumference (CIR), knee range of motion (ROM) and countermovement jump height (CMJ) collected before the first match and at the end of each day of competition. Changes over time in these markers were analyzed. Significant changes were found for all EIMD markers assessed. CMJ significantly decreased at the fourth day of competition when compared to baseline (0.41 ± 0.03 m vs. 0.45 ± 0.02 m). ROM decreased on the first day of competition and remained stable until the last day of competition (baseline: 126.5 ± 7.2º; 1st day: 115.8 ± 5.9º; 2nd day: 115 ± 7º; 3rd day: 113.9 ± 8.8º; 4th day: 114.4 ± 8.6º). SOR and CIR were increased at the second day of competition and remained altered thereafter. It was concluded that the characteristics of short-term condensed competition have led TH athletes to significant EIMD. If not avoided, EIMD might lead to reductions in performance in the most important (final) matches.

Resumo O objetivo do presente estudo foi medir o perfil neuromuscular de jogadores de handebol durante uma competição em formato de jogos. Nove jogadores de handebol (idade: 23 ± 3 anos; estatura: 176,2 ± 10,5 cm; massa: 75,3 ± 8,6 kg) jogaram cinco partidas da modalidade em cinco dias consecutivos e tiveram marcadores de DM [como percepção subjetiva de dor (PSD), circunferência da coxa (CIR), amplitude de movimento do joelho (ADM) e altura de salto com contra-movimento (AS)] coletados antes da primeira partida e ao final de cada dia de competição. Mudanças ao longo do tempo nesses marcadores foram analisadas. Alterações significantes foram encontradas para todos os marcadores de DM coletados. A AS diminuiu significantemente durante o quarto dia de competição, quando comparado ao valor basal (0,41 ± 0,03 m vs. 0,45 ± 0,02 m). A ADM diminuiu após o primeiro dia de competição e permaneceu comprometida até o último dia (basal: 126,5 ± 7,2º; 1o dia: 115,8 ± 5,9º; 2o dia: 115 ± 7º; 3odia: 113,9 ± 8,8º; 4o dia: 114,4 ± 8,6º). A PSD e a CIR apresentaram aumento durante o segundo dia de competição e permaneceram alteradas até o final da mesma. Concluímos que a característica condensada das competições de handebol no Brasil leva a um quadro de DM significante. Se não evitado, o DM pode levar a comprometimentos no desempenho nas partidas mais importantes da competição (finais).

RESUMO

The objective of this study was to evaluate how Brazilian anesthesiologists are using neuromuscular blockers (NMB), focusing on how they establish the diagnosis of postoperative residual curarization and the incidence of complications associated with the use of NMB. A questionnaire was sent to anesthesiologists inviting them to participate in the study. The online data collection remained open from March 2012 to June 2013. During the study period, 1296 responses were collected. Rocuronium, atracurium, and cisatracurium were the main neuromuscular blockers used in cases of elective surgery. Succinylcholine and rocuronium were the main NMB used in cases of emergency surgery. Less than 15% of anesthesiologists reported the frequent use of neuromuscular function monitors. Only 18% of those involved in the study reported that all workplaces have such a monitor. Most respondents reported using only the clinical criteria to assess whether the patient is recovered from the muscle relaxant. Most respondents also reported always using some form of neuromuscular blockade reversal. The major complications attributed to NMB were residual curarization and prolonged blockade. Eighteen anesthesiologists reported death attributed to NMB. Residual or prolonged blockade is possibly recorded as a result of the high rate of using clinical criteria to diagnose whether the patient has recovered or not from motor block and, as a corollary, the poor use of neuromuscular transmission monitors in daily practice.